Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial

NCT07736521 is registered in ClinicalTrials.gov with Mudher MB Alsunbuli as lead sponsor.

NCT NCT07736521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07736521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled Trial
Lead sponsor
Mudher MB Alsunbuli
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
May 1, 2027
Enrollment
66 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

facial pain, temporomandibular joint disorders, temporomandibular joint dysfunction syndrome